Early Patient Stories From a Cell Transplant Trial at University of Chicago

A small clinical trial at University of Chicago is testing an islet cell transplant procedure for people with Type 1 diabetes. Early reports from three patients show varied results, with some reducing insulin use.

Community video — lay discussion, not peer-reviewed research

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causespreventionimmune

Key takeaways

Three patients are currently enrolled in an islet cell transplant trial at University of Chicago Medicine
Early reports suggest mixed outcomes: one patient is off insulin, one is reducing insulin, and one reports improved quality of life
This is an early-stage trial with very limited participant numbers—results cannot yet be generalized
The procedure uses modified medication refined over 25 years to reduce harm to transplanted cells
Anyone interested in clinical trials should discuss options with their own doctors and conduct careful research

A Small Trial With Early Patient Experiences

University of Chicago Medicine is conducting a clinical trial of islet cell transplantation for people with Type 1 diabetes. Currently, three patients are enrolled in the study. According to early reports, one patient is off insulin entirely, another is beginning to reduce insulin doses with the goal of stopping altogether, and a third describes significant improvements in daily quality of life.

What the Procedure Involves

The trial uses islet cell transplantation—a procedure in which insulin-producing cells are transplanted into the body. The doctors involved describe using medication that has been refined and improved over 25 years to reduce toxicity and improve outcomes for transplanted cells.

One Patient's Story

One trial participant, Marena, has lived with Type 1 diabetes since age five. She reports experiencing severe low blood sugar episodes, including one where her daughter found her unconscious on the floor. After unsuccessful consultations with three other doctors about cell transplant trials, she contacted University of Chicago directly and was enrolled. She describes feeling more energetic and freer since joining the trial.

Important Context About This Report

This information comes from a community video and is not from peer-reviewed research. The trial involves only three patients—far too small a number to draw general conclusions about safety or effectiveness. Individual patient experiences do not predict outcomes for other people. Anyone interested in islet cell transplant or other clinical trials should discuss options with their own healthcare team and conduct thorough research through official clinical trial registries.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.